Liminal BioSciences Inc
Biotechnology
Healthcare
LMNL
3.10 M shares
NASDAQ US
traded
25 Sep 2023
listed
yes
open
8.48
52 week high
8.50
high
8.50
52 week low
1.35
low
8.48
growth
55.96 %
previous Close
8.48
P/E ratio
-5
market cap
27.20 M
div yield
0
usd
Mar 2023
qoq
revenue
136 K
-43.57 %
net incoming
-7.65 M
-60.27 %
eps
-1.77 %
23.03 %
eps surprise
0.00 %
net profit margin
-5623.53 %
-3643.00 %
operating incoming
-7.37 M
0.09 %
net change in cash
-10.20 M
-182.76 %
cash on hand
26.94 M
-27.47 %
cost of revenue
0.00 %
top top